Novel compounds II 2-pyridine derivatives as inhibitors of neutrophile elastase.

Details for Australian Patent Application No. 2006223675 (hide)

Owner AstraZeneca AB

Inventors Brimert, Thomas; Ray, Asim Kumar; Nikitidis, Antonios; Lawitz, Karolina; Lonn, Hans; Sandmark, Jenny

Agent Freehills

Pub. Number AU-B-2006223675

PCT Pub. Number WO2006/098684

Priority 0500604-4 16.03.05 SE

Filing date 14 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 3 December 2009

International Classifications

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/444 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 213/83 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/098684 Priority application(s): WO2006/098684

3 December 2009 Application Accepted

  Published as AU-B-2006223675

7 January 2010 Application for Amendment

  The nature of the amendment is: Amend the invention title to read 2-pyridine derivatives as inhibitors of neutrophile elastase. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000 2007

29 April 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read 2-pyridine derivatives as inhibitors of neutrophile elastase

29 April 2010 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223678-Examination table

2006223663-Micro-miniature implantable coated device